Ball Chad G, Butchart Michael, MacFarlane John K
University of Toronto School of Medicine, Ont.
Can J Surg. 2002 Aug;45(4):259-63.
To determine if the breast imaging reporting and data system (BI-RADS) defines a group of patients with mammographic abnormalities in whom stereotactic core needle biopsy (SCNB) is appropriate.
A blinded retrospective validation sample.
A university-affiliated hospital.
One hundred and nine consecutive patients who underwent fine-wire localization breast biopsy (FWLB) between Jan. 1, 1994, and June 1, 1999, with a known final pathological diagnosis.
Blinded mammographic review and classification using the BI-RADS; review of corresponding pathological findings from FWLBs.
Correlation of pathological findings with each BI-RADS category and analysis of the predictive value of clinical and radiologic features.
BI-RADS findings were as follows: 0 malignant lesions in 10 category 3 cases, 18 malignant lesions (3 in situ, 15 invasive) in 68 category 4 cases and 24 malignant lesions (8 in situ and 16 invasive) in 31 category 5 cases. There was 1 malignant lesion in 22 category 4 cases in women younger than 50 years.
SCNB should be applied to BI-RADS categories 3 and 4 (< 50 yr of age). FWLB should be reserved for category 4 (> 50 yr of age) and category 5 cases. This algorithm will reduce the morbidity and cost of breast biopsies in patients with nonpalpable mammographic abnormalities.
确定乳腺影像报告和数据系统(BI-RADS)是否能界定出一组适合进行立体定向粗针活检(SCNB)的乳腺钼靶异常患者。
一项盲法回顾性验证样本研究。
一家大学附属医院。
1994年1月1日至1999年6月1日期间连续109例行细针定位乳腺活检(FWLB)且最终病理诊断已知的患者。
采用BI-RADS进行盲法乳腺钼靶检查及分类;回顾FWLB的相应病理结果。
病理结果与各BI-RADS类别之间的相关性,以及临床和放射学特征的预测价值分析。
BI-RADS检查结果如下:10例3类病例中无恶性病变,68例4类病例中有18例恶性病变(3例原位癌,15例浸润性癌),31例5类病例中有24例恶性病变(8例原位癌和16例浸润性癌)。50岁以下女性的22例4类病例中有1例恶性病变。
SCNB应应用于BI-RADS 3类和4类(年龄<50岁)患者。FWLB应保留用于4类(年龄>50岁)和5类病例。该方案将降低乳腺钼靶检查异常但触诊不清的患者乳腺活检的发病率和成本。